Distribution of FMR1 alleles in the Vietnamese pregnant population: Implications for a national screening strategy
Nội dung chính của bài viết
Tóm tắt
The expansion of cytosine-guanine-guanine (CGG) trinucleotide repeats in the 5′-untranslated region (5’-UTR) of the FMR1 gene leads to a spectrum of multisystem conditions collectively referred to as FMR1-related disorders. This study aimed to evaluate the prevalence of FMR1 allele groups among 4,000 pregnant women, thereby elucidating the genetic landscape of FMR1 within the Vietnamese population. A multicenter cross-sectional study was conducted. Peripheral blood samples were obtained for genotyping, and data collection for analysis involving demographic, clinical, and family history. The observed frequencies of the normal, intermediate, and premutation allele carriers were 98.85%, 1.1%, and 0.05%, respectively, while no full mutation carriers were detected. A statistically significant association was observed between the distribution of FMR1 allele groups and risk stratification based on family history. The Vietnamese population may exhibit a lower risk for FMR1-related disorders. Consequently, a targeted screening strategy focusing on high-risk individuals, rather than universal screening, may be a more pragmatic and cost-effective approach within the Vietnamese healthcare context.
Chi tiết bài viết
Từ khóa
FMR1, Fragile X syndrome, premutation, pregnancy screening, population screening, screening strategy
Tài liệu tham khảo
2. Ciaccio C, Fontana L, Milani D, et al. Fragile X syndrome: a review of clinical and molecular diagnoses. Ital J Pediatr. Apr 19 2017; 43(1): 39.
3. Biancalana V, Glaeser D, McQuaid S, et al. EMQN best practice guidelines for the molecular genetic testing and reporting of fragile X syndrome and other fragile X-associated disorders. Eur J Hum Genet. Apr 2015; 23(4): 417-25.
4. Macpherson J, Sharif A. Practice guidelines for molecular diagnosis of Fragile X Syndrome. Association for Clinical Genetic Science 2014;
5. Gregg AR, Aarabi M, Klugman S, et al. Screening for autosomal recessive and X-linked conditions during pregnancy and preconception: a practice resource of the American College of Medical Genetics and Genomics (ACMG). Genet Med. Oct 2021; 23(10): 1793-1806.
6. Spector E, Behlmann A, Kronquist K, et al. Laboratory testing for fragile X, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG). Genet Med. May 2021; 23(5): 799-812.
7. Tempio A, Boulksibat A, Bardoni B, et al. Fragile X Syndrome as an interneuronopathy: a lesson for future studies and treatments. Front Neurosci. 2023; 17: 1171895.
8. Hunter J, Rivero-Arias O, Angelov A, et al. Epidemiology of fragile X syndrome: a systematic review and meta-analysis. Am J Med Genet A. Jul 2014; 164a(7): 1648-58.
9. Hall DA. In the Gray Zone in the Fragile X Gene: What are the Key Unanswered Clinical and Biological Questions? Tremor Other Hyperkinet Mov (N Y). 2014; 4: 208.
10. Genereux DP, Laird CD. Why do fragile X carrier frequencies differ between Asian and non-Asian populations? Genes & Genetic Systems. 2013; 88(3): 211-224.
11. Musci TJ, Caughey AB. Cost-effectiveness analysis of prenatal population-based fragile X carrier screening. Am J Obstet Gynecol. Jun 2005; 192(6): 1905-12; discussion 1912-5.
12. Toledano-Alhadef H, Basel-Vanagaite L, Magal N, et al. Fragile-X carrier screening and the prevalence of premutation and full-mutation carriers in Israel. Am J Hum Genet. Aug 2001; 69(2): 351-60.
13. Guo Q, Chang YY, Huang CH, et al. Population-based carrier screening and prenatal diagnosis of fragile X syndrome in East Asian populations. J Genet Genomics. Dec 2021; 48(12): 1104-1110.
14. Chiu HH, Tseng YT, Hsiao HP, et al. The AGG interruption pattern within the CGG repeat of the FMR1 gene among Taiwanese population. J Genet. Dec 2008; 87(3): 275-7.
15. Hnoonual A, Jankittunpaiboon C, Limprasert P. Screening for FMR1 CGG Repeat Expansion in Thai Patients with Autism Spectrum Disorder. Biomed Res Int. 2021; 2021:4359308.
16. Hung C-C, Lee C-N, Wang Y-C, et al. Fragile X syndrome carrier screening in pregnant women in Chinese Han population. Scientific Reports. 2019/10/29 2019; 9(1):15456.
17. Faradz SM, Pattiiha MZ, Leigh DA, et al. Genetic diversity at the FMR1 locus in the Indonesian population. Ann Hum Genet. Jul 2000; 64(Pt 4): 329-39.
18. Etyemez S, Esler A, Kini A, et al. The role of intellectual disability with autism spectrum disorder and the documented cooccurring conditions: A population-based study. Autism Res. Dec 2022; 15(12): 2399-2408.
19. Nolin SL, Glicksman A, Tortora N, et al. Expansions and contractions of the FMR1 CGG repeat in 5,508 transmissions of normal, intermediate, and premutation alleles. Am J Med Genet A. Jul 2019; 179(7): 1148-1156.
20. Limprasert P, Thanakitgosate J, Jaruthamsophon K, et al. Unique AGG Interruption in the CGG Repeats of the FMR1 Gene Exclusively Found in Asians Linked to a Specific SNP Haplotype. Genet Res Int. 2016; 2016: 8319287.
21. Zhao Y, Lu F, Wang X, et al. The economic burden of autism spectrum disorder with and without intellectual disability in China: A nationwide cost-of-illness study. Asian J Psychiatr. Feb 2024; 92:103877.
22. Committee Opinion No. 691: Carrier Screening for Genetic Conditions. Obstetrics & Gynecology. 2017; 129(3): e41-e55.
23. Zuñiga A, Juan J, Mila M, et al. Expansion of an intermediate allele of the FMR1 gene in only two generations. Clin Genet. Nov 2005; 68(5): 471-3.
24. Domniz N, Ries-Levavi L, Cohen Y, et al. Absence of AGG Interruptions Is a Risk Factor for Full Mutation Expansion Among Israeli FMR1 Premutation Carriers. Front Genet. 2018; 9:606.
25. Horn R, Kerasidou A, Merchant J. The value of large-scale programmes in human genomics. Eur J Hum Genet. May 2025; 33(5): 563-569.
26. Alarcón Garavito GA, Moniz T, Déom N, et al. The implementation of large-scale genomic screening or diagnostic programmes: A rapid evidence review. European Journal of Human Genetics. 2023/03/01 2023; 31(3): 282-295.
27. González-Teshima LY, Payán-Gómez C, Saldarriaga W. Fragile X Syndrome Secondary to in Vitro Fertilization With a Family Egg Donor: A Case Report and Review of the Literature. J Family Reprod Health. Jun 2021; 15(2): 130-135.
28. Wittenberger MD, Hagerman RJ, Sherman SL, et al. The FMR1 premutation and reproduction. Fertil Steril. Mar 2007; 87(3): 456-65.
29. Noto V, Harrity C, Walsh D, et al. The impact of FMR1 gene mutations on human reproduction and development: a systematic review. J Assist Reprod Genet. Sep 2016; 33(9): 1135-47.